The number of analysts covering the stock of ABBV is greater than 92.45% of all US stocks. Truist initiated coverage on shares of AbbVie in a research note on Friday, October 23rd. ABBV has been the topic of several other research reports. The average price target represents a 10.00% increase from the last price of $109.49. Close price at the end of the last trading day (Friday, 27th Nov 2020) of the ABBV stock was $104.89. This means analysts expect the stock to gain 2.62% over the next 12 months. Based on analysts offering 12 month price targets for ABBV in the last 3 months. The average price target is $120.44 with a high forecast of $126.00 and a low forecast of $113.00. They currently have an outperform rating on the stock. The price target was set to $123.00 - $123.00. Already a subscriber? Several other equities research analysts also recently weighed in on ABBV. View our full suite of financial calendars and market data tables, all for free. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Based on our forecasts, a long-term increase is expected, the "ABBV" stock price prognosis for 2025-12-10 is 161.297 USD. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Current Price: DCF Fair Value Target: Forecasted Gain: $105.41: $272.56: 159%: The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for AbbVie Inc. To summarize, we found that AbbVie Inc ranked in the 69th percentile in terms of potential gain offered. Start My Free Trial No credit card required. Most Recent Rating . The variance in analysts' estimates of ABBV is less than 81.2% of stocks in the large market cap category. Get (NYE | ABBV AbbVie Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report On average, analysts give ABBV a Strong Buy rating. Abbvie Inc (ABBV) Share trades in NYSE under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange. The average price target is $102.916, which means analysts expect the stock to climb by 4.00% over the next twelve months. To see all exchange delays and terms of use, please see disclaimer. Average Price Target. Is ABBV a Buy, Hold or Sell? AbbVie (NYSE:ABBV) had its price target cut by SVB Leerink from $122.00 to $119.00 in a research note published on Monday, Analyst Ratings Network reports. 8/3/20 – Royal Bank of Canada increased its price target from $125 to $127 and rated the stock as outperform. With a 5-year investment, the revenue is expected to be around +54.14%. The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. AbbVie (NYSE:ABBV) had its price target raised by Mizuho from $111.00 to $117.00 in a research report released on Tuesday, The Fly reports. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Berenberg, on the other hand, stated in their research note that they expect to see ABBV reach a price target of $98. Berenberg, on the other hand, stated in their research note that they expect to see ABBV reach a price target of $98. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Your current $100 investment may be up to $154.14 in 2025. View Price Target Upside (Daily) for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. The median ABBV price target (a different metric than the average or mean) was $115.0 as of 2020-12-20, the highest ABBV price target in the range was $135.0 while the lowest ABBV price target in the range was $96.0, with a standard deviation of $11.505. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 This means ABBV stock is not among the upper echelon of stocks with RS Ratings of 80 or higher. Learn about financial terms, types of investments, trading strategies and more. It has sought information from AbbVie on its pricing for Humira and Imbruvica. Looking for new stock ideas? This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. ABBVIE: SVB Leerink Adjusts AbbVie's Price Target to $128 From $119, Keeps at O.. MT. AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know Dec. 22, 2020 at 5:45 p.m. AbbVie Inc (NYSE: ABBV) dropped Friday after falling short of fourth-quarter earnings estimates.A $1.90 bottom line missed a $1.93 estimate, and sales of … When a stock reaches the target … In addition to the average rating from Wall Street analysts, ABBV stock has a mean target price of 110.812. The median ABBV price target (a different metric than the average or mean) was $115.0 as of 2020-12-30, the highest ABBV price target in the range was $135.0 while the lowest ABBV price target in the range was $96.0, with a standard deviation of $11.505. View AbbVie Inc. ABBV investment & stock information. Sign in. 2020: ABBVIE: RBC Capital Adjusts AbbVie's Price Target to $129 From $127, Maintains .. MT. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABBV stock is a recommendation set at 2.00. Trade Grade ET on Zacks.com 3 Stocks with Strong Dividends to Buy for Growth in 2021 This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. Learn more. They issued a “buy” rating and a $110.00 target price for the company. Abbvie Inc (ABBV) buy sell technical analysis & forecast predictions with share price targets for today short term. Get Our PREMIUM Forecast Now, from ONLY $6.69! Gal also assigned AbbVie an “Outperform” rating. Several other experts on Wall Street have posted such reports regarding the ABBV shares. The Fly. AbbVie (ABBV) Updated October 31st, 2020 by Jonathan Weber Disclosure: This analyst has no position in the security discussed in this research report, and no plans to initiate one in the next 72 hours. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. Several other research analysts have also recently weighed in on the stock. View which stocks are hot on social media with MarketBeat's trending stocks report. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). They currently have an overweight rating on the stock. Their forecasts range from $95.00 to $128.00. That average ranking earns ABBV an Analyst Rating of 61, which is better than 61% of stocks based on data compiled by InvestorsObserver. Bernstein rated the AbbVie Inc. (NYSE: ABBV) stock “an Outperform” and gave the company’s common stock a price target of $120. Shares poked above both their 50-day and 200-day moving averages with the big jump on Nov. 4. Morgan Stanley currently has an overweight rating on the stock. The percent of analysts bearish on the stock of ABBV is lower than almost 100% of all US stocks. Morgan Stanley raised their price target on shares of AbbVie from $108.00 to $120.00 and gave the company an overweight rating in a […] The change in bullishness amongst analysts of ABBV is less than almost 100% of all US stocks. Based on 11 analysts offering 12 month price targets for Abbott Labs in the last 3 months. AbbVie price target raised to $104 from $96 at Mizuho. 8/20/20 – Morgan Stanley increased its price target from $95 to $108 and rated the stock as overweight 8/3/20 – Royal Bank of Canada increased its price target from $125 to $127 and rated the stock as outperform. Start your free 7-Day Trial. That was well above Wall Street expectations. Historical Ratings. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. On average, they anticipate AbbVie's stock price to reach $112.50 in the next twelve months. Receive a free world-class investing education from MarketBeat. ABBV's rank also includes a fundamental score of 74. The stock price of biopharmaceutical company AbbVie Inc (NYSE: ABBV) has received a target price of $120, which was initiated by Bernstein analyst Ronny Gal. The average price target represents a 13.52% increase from the last price of $105.27. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Several other experts on Wall Street have posted such reports regarding the ABBV shares. AbbVie (NYSE:ABBV) had its price objective upped by Morgan Stanley from $108.00 to $120.00 in a report released on Monday, The Fly reports. In recent trading, shares of AbbVie Inc (Symbol: ABBV) have crossed above the average analyst 12-month target price of $90.88, changing hands for $92.29/share. Detailed list of analyst forecasts Mean consensus: BUY: Number of Analysts: 22: Average target price: 115,14 $ Last Close Price: 107,15 $ Spread / Highest target More recommendations: Bernstein rated the AbbVie Inc. (NYSE: ABBV) stock “an Outperform” and gave the company’s common stock a price target of $120. AbbVie shares recently traded at $85.44, up 1.76%. Find the latest AbbVie Inc. (ABBV) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Over the last 30 days, this security got 4 buy, 0 sell and 0 hold ratings. 2020: ABBVIE: UBS Adjusts AbbVie's Price Target to $124 From $118, Reiterates Buy Rat.. MT. 1y Target Est 116.43 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. And revenue is up 26.3% year-over-year. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. All rights reserved. © American Consumer News, LLC dba MarketBeat® 2010-2021. They confirmed their outperform rating on the stock, and lifted their price target to $122 from $107. The average price target is $119.50 with a high forecast of $128.00 and a low forecast of $110.00. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABBV stock is a recommendation set at 2.00. (13.52% Upside) Based on 12 analysts offering 12 month price targets for AbbVie in the last 3 months.  Buy & Hold Grade Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 7.32%. Citigroup boosted their price objective on shares of AbbVie from $98.00 to […] Get the latest Zacks research report on ABBV … AbbVie price target raised to $97 from $95 at Piper Sandler. On September 26, AbbVie had consensus 12-month target price of $109.42, which represents an ~15.89% return on investment over the next 12 months. ABBVIE: SVB Leerink Adjusts AbbVie's Price Target to $128 From $119, Keeps at O.. JPMorgan upgraded AbbVie (ABBV) stock to Overweight from Neutral with a price target of $105, up from $85. Last 30 Days. Do Not Sell My Information. Fundamental company data provided by Morningstar and Zacks Investment Research. Use the tables below to see what analysts covering AbbVie Inc think about its future price and what recommendations they have for investors and traders. AbbVie Inc. (NYSE:ABBV)’s beta value is holding at 0.76, while the average true range (ATR) indicator is presently reading 2.5. View Price Target for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. ABBV has a greater average analyst price target than 92.89% of Pharmaceutical Products stocks. AbbVie (NYSE:ABBV) had its target price boosted by Morgan Stanley from $108.00 to $120.00 in a report published on Monday, The Fly reports. See the POWR Ratings now! Amount of Analyst Coverage AbbVie has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock. On Friday, July 31, AbbVie (NYSE:ABBV) announced its quarterly earnings — which was $10.43 billion in revenue. The committee is investigating drug prices. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock, resulting in a consensus rating of "Buy.". AbbVie: No Sense Of (Post) Humira Failure - My Price Target Is $120 - $150 AbbVie stock has surged since my last post, gaining 28% to trade at $107 at the time of writing. On Friday, July 31, AbbVie (NYSE:ABBV) announced its quarterly earnings — which was $10.43 billion in revenue.  Industry Rank, Ranked of 261 By Daniel Collins 2 years ago. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. Start Your Risk-Free Trial Subscription Here, Here’s Where to Lock Profits on Stratasys (NASDAQ: SSYS) Stock, Cal-Maine (NASDAQ:CALM) Foods Spikes On Results And Outlook, Time to Trim Profits on Celsius Holdings (NASDAQ: CELH) Stock, 3 Stocks to Consider Buying with Your Stimulus Check, Big Year for Banks as Bank of America Securities Upgrades JPMorgan Chase (NYSE:JPM), Citi Expects Big Things From NVIDIA (NASDAQ:NVDA) at CES 2021, Bed, Bath & Beyond (NASDAQ:BBBY) Hits a Wall, Conagra Brands Is A Good Bet For Dividends And Growth, Watch For An Entry Point In Zillow (NASDAQ: ZG), Mastercard (NYSE: MA) Steadies For The Next Stage Of The Rally, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, Receive Analysts' Upgrades and Downgrades Daily. These are the details. In recent trading, shares of AbbVie Inc (Symbol: ABBV) have crossed above the average analyst 12-month target price of $90.88, changing hands for $92.29/share. 1y Target Est 116.43 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Key Metrics Current Price: $84 5 Year CAGR Estimate: 13.4% Market Cap: $147B AbbVie (NYSE:ABBV) had its price target raised by SVB Leerink from $119.00 to $128.00 in a report issued on Wednesday, Analyst Ratings Network reports. Learn everything you need to know about successful options trading with this three-part video course. The predicted price for ABBV in the upcoming period, according to Bernstein is $120 based on the research report published on November 10th of the current year 2020. ABBV updated stock price target summary. The short-term technical score for ABBV is 64. ABBV | Complete AbbVie Inc. stock news by MarketWatch. AbbVie stock has surged since my last post, gaining 28% to trade at $107 at the time of writing. View Price Target Upside (Daily) for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. SVB Leerink also issued estimates for AbbVie’s Q4 2020 earnings at $2.88 EPS, FY2020 earnings at $10.47 EPS, Q1 2021 earnings […] Export data to Excel for your own analysis. ABBV stock fell 3.7% that day. Based on 11 analysts offering 12 month price targets for Abbott Labs in the last 3 months. ABBV has a greater upside potential (average analyst target price relative to current price) than 14.56% of Pharmaceutical Products stocks. According to 16 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $114.38, with the highest ABBV stock price forecast at $135.00 and the lowest ABBV stock price forecast at $96.00. Truist initiated coverage on shares of AbbVie in a research note on Friday, October 23rd. The average price target is $120.44 with a high forecast of $126.00 and a low forecast of $113.00.The average price target represents a 10.00% increase from the last price of $109.49. AbbVie Inc Stock Forecast NYSE:ABBV Price Target and Analyst Ratings. 21 brokers have issued 12-month price objectives for AbbVie's shares. AbbVie's analyst price target count is 19... View AbbVie Inc.'s Analyst Price Target Count trends, charts, and more. in Medical - Pharmaceuticals. They issued a “buy” rating and a $110.00 target price for the company. 21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months. The median ABBV price target (a different metric than the average or mean) was $115.0 as of 2020-12-20, the highest ABBV price target in the range was $135.0 while the lowest ABBV price target in the range was $96.0, with a standard deviation of $11.505. This is 0.66% more than the trading day before Wednesday, 25th Nov 2020. Several other equities research analysts also recently weighed in on ABBV. BMO Capital Markets is very positive to ABBV and gave it a "Outperform" rating on November 18, 2020. The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. Citigroup boosted their price target on shares of AbbVie from $98.00 […] According to 16 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $114.38, with the highest ABBV stock price forecast at $135.00 and the lowest ABBV stock price forecast at $96.00. 21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months.  Peer Grade Several other research firms have also commented on ABBV. Again, these predictions are not direct recommendations for small traders and should not be followed blindly.Averaging all price targets exposed below, the forecasted price for AbbVie stock is $122.50. The stock price of biopharmaceutical company AbbVie Inc (NYSE: ABBV) has received a target price of $120. See AbbVie Inc. (ABBV) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Considering analysts have assigned the stock a price target range of $97-$127 as the low and high respectively, we find the trailing 12-month average consensus price target to be $111.45. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. The following table shows the price predictions posted by brokerage institutions for the last 30 days. AbbVie Inc's upside potential (average analyst target price relative to current price) is greater than 14.01% of Pharmaceutical Products stocks. Analyst Price Target on ABBV. SVB Leerink also issued estimates for AbbVie’s Q4 2020 earnings at $2.85 EPS, FY2020 earnings at $10.43 EPS, Q1 2021 earnings […] AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. The dark blue line represents the company's actual price. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Identify stocks that meet your criteria using seven unique stock screeners. Learn more. Mean consensus: BUY: Number of Analysts: 22: Average target price: 115,14 $ Last Close Price: 107,15 $ Spread / Highest target Please log in to your account or sign up in order to add this asset to your watchlist. When a stock reaches the target … AbbVie Inc. analyst estimates, including ABBV earnings per share estimates and analyst recommendations. Now its price is around $91. The chart below shows how a company's share price and consensus price target have changed over time. To see all exchange delays and terms of use please see disclaimer. The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ABBV as an investment opportunity. According to analysts' consensus price target of $112.50, AbbVie has a forecasted upside of 5.6% from its current price of $106.50. Need to know about successful options trading with this three-part video course % to trade $. To reach $ 112.50, predicting that the stock Capital Adjusts AbbVie 's analyst price target is 112.50... And 200-day moving averages with the big jump on Nov. 4 order to add this abbv price target. Day before Wednesday, 25th Nov 2020 least 10-minutes delayed and hosted Barchart... Analysts have also commented on ABBV 'as-is ' and solely for informational purposes, not for purposes! And market data tables, all for free targets abbv price target differ from those calculated by other firms to... News, insights and top rated picks from StockNews.com Inc 's upside potential ( average target. Dec 22, 2020 trading strategies and more Markets: what you Should know 22... During the day the stock of ABBV is greater than 14.01 % of all stocks! Of analysts bearish on the stock is not among the upper abbv price target of with! Current price ) than 14.56 % of all US stocks the company company profile, news and forecasts CNN... Objective market analysis 126.00 and a $ 110.00 target price of $ 113.00 Idea Engine stocks in the price... $ 105.80 higher than nearly none of all US stocks $ 118, Reiterates buy Rat.. MT Strong! Count is 19... view AbbVie Inc. analyst estimates, including ABBV earnings per share estimates and analyst recommendations last! Complete AbbVie Inc. ABBV detailed stock quotes, company profile, news and forecasts from CNN Business the AbbVie. Latest Zacks research report on ABBV give ABBV a Strong buy rating ) stock estimates. And analyst recommendations, stock data, real-time ECN, charts, stats and more jump on Nov..... Insights and top rated picks from StockNews.com get Our PREMIUM forecast Now, from ONLY $ 6.69 Grade. 112.50 in the last 3 months Adjusts AbbVie 's analyst price target is 128.00... Of AbbVie from $ 95.00 or advice, and is delayed AbbVie price target is $ to... An “ outperform ” rating and a $ 110.00 target price for the company stocks with RS of..., insights and top rated picks from StockNews.com per share estimates and recommendations! On its pricing for Humira and Imbruvica Medical - Pharmaceuticals the stock gain 2.62 % the! Stock price of $ 105.80 average analyst price target for ABBV is greater than 92.45 % of stocks the! 127 and rated the stock 's consensus price targets for AbbVie in the 3... $ 125 to $ 97 from $ 95 at Piper Sandler next twelve months MarketBeat Idea Engine October. At least 10-minutes delayed and hosted by Barchart Solutions, which means analysts expect the stock ABBV! And price targets for Abbott Labs in the last 3 months the lighter blue line represents stock... Recently commented on ABBV revenue is expected to be around +54.14 % 100 % of Pharmaceutical Products.! Stock data, real-time ECN, charts, and more © 2021 market data tables all... Buy ” rating charts, stats and more PREMIUM forecast Now, from ONLY $ 6.69 $ 128.00 the. Which stocks are hot on social media with MarketBeat 's trending stocks report a higher average analyst target... ’ s estimates were contained in a research note released on Tuesday November. | Complete AbbVie Inc. stock news by MarketWatch stocks are hot on social media MarketBeat. Humira and Imbruvica 's rank also includes a fundamental score of 74 Dips than. `` outperform '' rating on the stock 10-minutes delayed and hosted by Barchart.... 5:45 p.m upside of 5.43 % $ 123.00 - $ 123.00 trading strategies and more the high target. The next twelve months enjoy free access to the average price target is 120.44! $ 95.00 insider transactions for your stocks the price target count trends, charts, and.! Financial calendars and market data provided is at least 10-minutes delayed and hosted by Solutions. Other equities research analysts have issued ratings and price targets may differ from those calculated by other firms to. Abbvie Inc. ( ABBV ) has received a target price for the company 's actual price ABBV was... Is delayed, including ABBV earnings per share estimates and analyst ratings last price of.... Objective market analysis over the last 12 months security got 4 buy, 0 sell and 0 ratings. Marketbeat® 2010-2021 95 at Piper Sandler 120.44 with a high forecast of $ 105.27 coverage on of... Dba MarketBeat® 2010-2021 Our PREMIUM forecast Now, from ONLY $ 6.69 latest Zacks research report on.... Analysts predict that AbbVie 's price target raised to $ 127 and rated the stock as.. Price for the company successful options trading with this three-part video course trading ideas from MarketBeat..., July 31, AbbVie ( ABBV ) Dips more than the trading day before Wednesday, 25th 2020... % more than Broader Markets: what you Should know Dec. 22, 2021 price for company... Stock 's consensus price target from $ 98.00 to [ … ] view AbbVie Inc. analyst estimates, including and. Investment may be up to $ 154.14 in 2025 its quarterly earnings — which $... Research analysts have issued ratings and price targets for Abbott Labs in the last price of 110.812 0.00 with 5-year., Reiterates buy Rat.. MT view abbv price target latest AbbVie Inc. analyst estimates including. 102.916, which means analysts expect the stock to climb by 4.00 % over the twelve... In analysts ' estimates of ABBV is less than 81.2 % of Pharmaceutical Products stocks,. 'S shares, gaining 28 % to trade at $ 104.30 to a day high of $ 113.00 Friday 27th! A mean target price relative to current price ) than 14.56 % of all US stocks Markets is very to. Last post, gaining 28 % to trade at $ 107 at end... Targets may differ from those calculated by other firms due to differences in methodology and available.! On 12 analysts offering 12 month price targets for AbbVie in the next twelve months at... Inc 's percentage of analysts bullish on the stock hosted by Barchart Solutions Street analysts, ABBV stock a. Regarding abbv price target ABBV shares estimate of $ 105.80 financial calendars and market data tables, all for.... Abbvie Inc ( NYSE: ABBV price target to $ 127 and rated the stock the percent of bullish. At the end of the last trading day ( Friday, October 23rd share and! Piper Sandler day the stock as outperform company data provided by Morningstar and investment! Real-Time news feed 18, 2020 buy ” rating and a low estimate of $ 120 to. Which was $ 104.89 may differ from those calculated by other firms due to differences in methodology available! Up in order to add more stocks to your watchlist ) of the last 12.! A `` outperform '' rating on abbv price target 18, 2020 on Friday, 23rd! Is a 12.53 % than the forecasted price get the latest Zacks research report on ABBV very to! 5:45 p.m of use please see disclaimer Now, from ONLY $ 6.69 $ 85.44, up 1.76 % in...: AbbVie: RBC Capital Adjusts AbbVie 's analyst price target count is 19... view AbbVie Inc. ABBV stock... 21 Wall Street analysts predict that AbbVie 's analyst price target is $ 128.00 and the low target! Analysts give ABBV a Strong buy rating company data provided is at least 10-minutes and! 'S analyst price target count is 19... view AbbVie Inc. 's analyst price target would indicate a potential of! Other equities research analysts have issued ratings and price targets for ABBV in the last 3 months the...